TCL Archive Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients. April 9, 2010
TCL Archive FDA, NCI united in pursuit of 2015 goal, Andrew von Eschenbach tells cancer center directors; says his appointment was necessary to “maintain the momentum of the FDA.” October 21, 2005
TCL Archive FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI April 15, 1977
